Thumb-tack needles based on "Biaoben acupoint compatibility" for sequela of COVID-19 during recovery period.
10.13703/j.0255-2930.20210406-0004
- Author:
Zhi-Hui LUO
1
;
Kun-Xiu WANG
1
;
Yan-Lin ZHANG
1
;
Zi-Qin CHEN
1
;
Bei CHEN
1
;
Jia CHEN
1
;
Ting ZHOU
1
;
Xiao-Lei GU
1
;
Chong-Li LI
1
;
Peng YAN
2
;
Ling-Ling TIAN
2
;
Chi-Cheng XU
2
;
Bo-Lin CHEN
2
;
Song CHEN
3
,
4
Author Information
1. College of Acupuncture-Moxibustion and Orthopaedics, Hubei University of CM, Wuhan 430061, China.
2. Department of Rehabilitation, Jingzhou Second People's Hospital, Jingzhou 434000, Hubei Province.
3. College of Acupuncture-Moxibustion and Orthopaedics, Hubei University of CM, Wuhan 430061, China
4. Department of Rehabilitation, Jingzhou Second People's Hospital, Jingzhou 434000, Hubei Province.
- Publication Type:Randomized Controlled Trial
- Keywords:
Biaoben acupoint compatibility;
coronavirus disease 2019 (COVID-19);
recovery stage;
sequela;
thumb-tack needles
- MeSH:
Acupuncture Points;
Anxiety/etiology*;
COVID-19/therapy*;
Depression/etiology*;
Humans;
Needles;
Respiratory Function Tests;
Thumb
- From:
Chinese Acupuncture & Moxibustion
2022;42(3):281-286
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To observe the effect of thumb-tack needles based on "Biaoben acupoint compatibility" on sequela symptoms, mental state and pulmonary ventilation function in patients with coronavirus disease 2019 (COVID-19) during recovery period.
METHODS:Fifty cases of COVID-19 during recovery period were randomly divided into an observation group and a control group, 25 cases in each group. The patients in the observation group were treated with thumb-tack needles at Guanyuan (CV 4), Zusanli (ST 36) and Taiyuan (LU 9). The patients in the control group were treated with sham thumb-tack needles at identical acupoints as the observation group. The treatment in the two groups was given once a day, 7-day treatment was taken as a course of treatment, and totally two courses of treatment were given. The TCM symptom score, Hamilton anxiety scale (HAMA) score, Hamilton depression scale (HAMD) score, pulmonary function (forced vital capacity [FVC], forced expiratory volume in the first second [FEV1], peak expiratory flow [PEF]), the severity of pulmonary ventilation dysfunction and pulmonary imaging changes in the two groups were compared before and after treatment.
RESULTS:Compared before treatment, the total scores and each item scores of TCM symptom scale, HAMA scores and HAMD scores in the two groups were reduced after treatment (P<0.05). Except for the symptom scores of dry throat and dry stool, the total score and each item score of TCM symptom scale, HAMA score and HAMD score in the observation group were lower than those in the control group (P<0.05). Compared before treatment, FVC, FEV1 and PEF in the two groups were increased after treatment (P<0.05), and those in the observation group were higher than the control group (P<0.05). The severity of pulmonary ventilation dysfunction in the two groups was reduced after treatment (P<0.05), and the severity in the observation group was better than that in the control group (P<0.05). After treatment, the lung shadow area in the two groups was decreased (P<0.05), and that in the observation group was smaller than the control group (P<0.05). The improvement of imaging change in the observation group was better than that in the control group (P<0.05).
CONCLUSION:The thumb-tack needles based on "Biaoben acupoint compatibility" could significantly reduce the sequela symptoms, anxiety and depression in patients with COVID-19 during recovery stage, and improve the pulmonary ventilation function.
